602 related articles for article (PubMed ID: 19920380)
1. [Present status of carbon ion radiotherapy for malignant tumors].
Sugahara S; Kamada T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experience of carbon ion radiotherapy for malignant tumors].
Ishikawa H; Tsuji H; Tsujii H
Gan To Kagaku Ryoho; 2006 Apr; 33(4):444-9. PubMed ID: 16612151
[TBL] [Abstract][Full Text] [Related]
3. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas.
Serizawa I; Kagei K; Kamada T; Imai R; Sugahara S; Okada T; Tsuji H; Ito H; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1105-10. PubMed ID: 19467578
[TBL] [Abstract][Full Text] [Related]
4. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
[TBL] [Abstract][Full Text] [Related]
5. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.
Yanagi T; Mizoe JE; Hasegawa A; Takagi R; Bessho H; Onda T; Kamada T; Okamoto Y; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):15-20. PubMed ID: 19046826
[TBL] [Abstract][Full Text] [Related]
6. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
[TBL] [Abstract][Full Text] [Related]
7. Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II dose-escalation study.
Tsuji H; Ishikawa H; Yanagi T; Hirasawa N; Kamada T; Mizoe JE; Kanai T; Tsujii H; Ohnishi Y;
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):857-62. PubMed ID: 17161555
[TBL] [Abstract][Full Text] [Related]
8. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
9. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
[TBL] [Abstract][Full Text] [Related]
10. Application of carbon-ion beams or gamma-rays on primary tumors does not change the expression profiles of metastatic tumors in an in vivo murine model.
Tamaki T; Iwakawa M; Ohno T; Imadome K; Nakawatari M; Sakai M; Tsujii H; Nakano T; Imai T
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):210-8. PubMed ID: 19362239
[TBL] [Abstract][Full Text] [Related]
11. Examination of GyE system for HIMAC carbon therapy.
Kanai T; Matsufuji N; Miyamoto T; Mizoe J; Kamada T; Tsuji H; Kato H; Baba M; Tsujii H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):650-6. PubMed ID: 16414376
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy with carbon ion beams for prostate cancer.
Tsuji H; Yanagi T; Ishikawa H; Kamada T; Mizoe JE; Kanai T; Morita S; Tsujii H;
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1153-60. PubMed ID: 15990247
[TBL] [Abstract][Full Text] [Related]
13. Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer.
Sugane T; Baba M; Imai R; Nakajima M; Yamamoto N; Miyamoto T; Ezawa H; Yoshikawa K; Kandatsu S; Kamada T; Mizoe J; Tsujii H
Lung Cancer; 2009 Apr; 64(1):45-50. PubMed ID: 18762351
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II clinical trials of carbon ion therapy for prostate cancer.
Akakura K; Tsujii H; Morita S; Tsuji H; Yagishita T; Isaka S; Ito H; Akaza H; Hata M; Fujime M; Harada M; Shimazaki J;
Prostate; 2004 Feb; 58(3):252-8. PubMed ID: 14743464
[TBL] [Abstract][Full Text] [Related]
15. Carbon-ion radiation therapy for prostate cancer.
Ishikawa H; Tsuji H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Tsujii H;
Int J Urol; 2012 Apr; 19(4):296-305. PubMed ID: 22320843
[TBL] [Abstract][Full Text] [Related]
16. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
17. [Heavy charged particle radiotherapy--proton beam].
Ogino T
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2030-5. PubMed ID: 14712761
[TBL] [Abstract][Full Text] [Related]
18. Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience.
Jereczek-Fossa BA; Krengli M; Orecchia R
Head Neck; 2006 Aug; 28(8):750-60. PubMed ID: 16804876
[TBL] [Abstract][Full Text] [Related]
19. [Proton beam therapy].
Ogino T
Gan To Kagaku Ryoho; 2006 Apr; 33(4):450-4. PubMed ID: 16612152
[TBL] [Abstract][Full Text] [Related]
20. [Present status of high LET radiation therapy--fast neutron radiotherapy in Japan].
Morita S; Tsunemoto H; Aoki Y; Kubota S; Nakano T; Gomi H; Kumagaya K; Arai T; Sato S; Iino Y
Gan No Rinsho; 1987 Oct; 33(13):1647-54. PubMed ID: 3121893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]